Changes in Tumor Vascularity Depicted by Contrast-Enhanced EUS as a Predictor of Prognosis and Treatment Efficacy in Patients With Unresectable Pancreatic Cancer (PEACE): A Study Protocol

Endoscopic Ultrasound - India
doi 10.4103/eus.eus_16_19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medknow

Related search

Changes in Tumor Vascularity Depicted by Contrast-Enhanced Ultrasonography as a Predictor of Chemotherapeutic Effect in Patients With Unresectable Pancreatic Cancer

Suizo
2009English

Reduced miRNA-218 Expression in Pancreatic Cancer Patients as a Predictor of Poor Prognosis

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Intra-Arterial and Tumor-Targeted Infusion of Gemcitabine in Patients With Unresectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2016English

Dynamic Contrast-Enhanced MRI in Monitoring Changes in Tumor-Associated Stroma During Treatment With Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Impact of the Treatment of Pancreatic Exocrine Insufficiency on Survival of Patients With Unresectable Pancreatic Cancer: A Retrospective Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Systematic Review of FOLFIRINOX in Patients With Locally Unresectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2016English

Efficacy of Minimally Invasive Therapies on Unresectable Pancreatic Cancer

Chinese Journal of Cancer
2013English

Early Diagnosis of Pancreatic Cancer by EUS

Suizo
2017English

Chromogranin a Is a Predictor of Prognosis in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy